BIOCRYST PHARMACEUTICALS INC Business Operations Contracts & Agreements

21 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
the preclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO(berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
the preclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO(berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2022
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
AL
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
AL
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
DE
2021
thepreclinical development, clinical development, commercialization, or post-marketing studies of our products and product candidates, including ORLADEYO (berotralstat), BCX9930,...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2021
Amendment #9 to the Agreement between BioCryst Pharmaceuticals, Inc. and the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2018
MUTUAL TERMINATION AND RELEASE AGREEMENT
Termination Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2012
VOTING AND POST-CLOSING LOCK-UP AGREEMENT
Voting Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2012
Name TitleWilliam P. Sheridan, M.D. Chief Medical Officer, Principal InvestigatorElliott Berger, Ph.D. Sr. Vice President, Regulatory AffairsWalter G. Gowan, Ph.D. Vice President...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2009
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES 1 1 2. AMENDMENT/MODIFICATION NO: 3. EFFECTIVE DATE 4. REQUISITION/PURC 5. PROJECT NO. (If...
Development Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2008
LICENSE AGREEMENT BETWEEN ALBERT EINSTEIN COLLEGE OF MEDICINE, INDUSTRIAL RESEARCH, LTD AND BIOCRYST PHARMACEUTICALS, INC. Statement 1 1. Definitions 2 1.01 Field 2 1.02 Agreement...
Termination Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
NY
2005
Placement Agency Agreement
Agency Agreements
BIOCRYST PHARMACEUTICALS INC
Biotechnology
2005